Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Therapy
WelChol improves glycemic control in patients with uncontrolled Type 2 diabetes on insulin
December 11th, 2006
Data presented at the American Heart Association's (AHA) Scientific Sessions 2006 in Chicago demonstrated that WelChol (colesevelam HCl), when added to insulin in uncontrolled patients with type 2 diabetes mellitus, improves glycemic control. This is the first study ever to evaluate WelChol in combination with insulin, and it demonstrated A1C reductions of 0.5 percent compared to placebo (-0.41% vs. +0.09%, p <0.001). The same A1C effect was demonstrated in a smaller WelChol study presented at the American Diabetes Association's (ADA) annual scientific sessions. The Glucose Lowering Effect Of WelChol Study (GLOWS) demonstrated that WelChol added to oral antidiabetic...
Source: Obesity & Diabetes Week (2006-12-11)
|
